Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders
S Singh, AS Grewal, R Grover, N Sharma, B Chopra… - Bioorganic …, 2022 - Elsevier
The aim of this review was to discuss an overview of type 2 diabetes; biology of PTP1B; role
of PTP1B in metabolic disorders; and recent updates in the development of PTP1B inhibitors …
of PTP1B in metabolic disorders; and recent updates in the development of PTP1B inhibitors …
Calixarene-based pure and mixed assemblies for biomedical applications
Y Razuvayeva, R Kashapov… - Supramolecular …, 2020 - Taylor & Francis
The spontaneous preparation of well-defined functional nanoscale systems is very
important, since this formulation process requires additional resources, external supply of …
important, since this formulation process requires additional resources, external supply of …
Phosphonated calixarene as a “molecular glue” for protein crystallization
Protein crystallization remains a serious bottleneck to structure determination by X-ray
diffraction methods. Compounds acting as “molecular glue” provide a promising strategy to …
diffraction methods. Compounds acting as “molecular glue” provide a promising strategy to …
Calixarene-based phosphinic acids as inhibitors of protein tyrosine phosphatases
VM Buldenko, VV Trush, OL Kobzar… - Bioorganic & medicinal …, 2019 - Elsevier
In the present work, the derivatives of calix [4] arene, thiacalix [4] arene, and sulfonylcalix [4]
arene bearing four methylene (phenyl) phosphinic acid groups on the upper rim of the …
arene bearing four methylene (phenyl) phosphinic acid groups on the upper rim of the …
Crystal structure of a protein–aromatic foldamer composite: macromolecular chiral resolution
JM Alex, V Corvaglia, X Hu, S Engilberge… - Chemical …, 2019 - pubs.rsc.org
Co-crystallization of a 2 kDa tether-free sulfonated foldamer and the 13 kDa lysine-rich
cytochrome c yielded a remarkable biohybrid assembly with chiral resolution of the foldamer …
cytochrome c yielded a remarkable biohybrid assembly with chiral resolution of the foldamer …
Modification of oligolactic acid with tetracarboxylic p-tert-butylthiacalix [4] arene derivatives: effect of macrocyclic fragment configuration on aggregation and thermal …
RI Kh - Макрогетероциклы, 2017 - cyberleninka.ru
A novel approach to modification of oligolactic acid with three stereoisomers (cone, partial
cone, 1, 3-alternate) of p-tert-butylthiacalix [4] arene carboxylate derivatives has been …
cone, 1, 3-alternate) of p-tert-butylthiacalix [4] arene carboxylate derivatives has been …
Functional calixarenes for material and life science
R Rodik, S Cherenok, O Kalchenko… - Current Organic …, 2018 - ingentaconnect.com
Calix [n] arenes–are easily accessible three-dimensional macrocyclic compounds. Modified
calix [n] arenes capable with high selectivity recognize, bind in supramolecular complexes …
calix [n] arenes capable with high selectivity recognize, bind in supramolecular complexes …
Calixarene derivatives for (nano) biotechnologies
This review summarizes the author's research in the field of bio-medical application of
modified calixarenes as well as their nano-associates. The paper includes results of design …
modified calixarenes as well as their nano-associates. The paper includes results of design …
Complexation of water-soluble phosphorylated calixarenes with uracils. Stability constants and DFT study of the supramolecular complexes
OI Kalchenko, AB Rozhenko, SO Cherenok… - Journal of Inclusion …, 2023 - Springer
Modification of the upper rim of the lipophilic cone-shaped tetrapropoxycalix arene with
hydrophilic phosphine oxide groups or phosphinic acid groups yielded nano-sized water …
hydrophilic phosphine oxide groups or phosphinic acid groups yielded nano-sized water …
Sulfonyl-bridged calix [4] arene as an inhibitor of protein tyrosine phosphatases
V Buldenko, O Kobzar, V Trush… - French-Ukrainian …, 2017 - kyivtoulouse.univ.kiev.ua
Previously, phosphonic acid derivatives of calix [4] arene and thiacalix [4] arene were found
to be potential inhibitors of protein tyrosine phosphatase 1B. In the present paper, the …
to be potential inhibitors of protein tyrosine phosphatase 1B. In the present paper, the …